Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sildenafil for the Treatment of Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage

NCT03028298 is registered in ClinicalTrials.gov with University of Mississippi Medical Center as lead sponsor.

NCT NCT03028298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03028298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sildenafil for the Treatment of Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage
Lead sponsor
University of Mississippi Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
December 31, 2016
Completion date
July 31, 2023
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vasospasm, subarachnoid hemorrhage